Mucosolvan 1mal Täglich (Ambroxol Hydrochloride)

Ambroxol stimulates serous cells in the airway lining, increasing the secretion of thin, watery fluid. This reduces mucus viscosity and enhances ciliary movement, allowing the body to clear secretions more efficiently. The drug also has mild local anesthetic and anti‑inflammatory actions that can lessen cough irritation.

The appropriate dose of Mucosolvan 1mal Täglich is determined by the prescribing healthcare professional based on the patient’s age, condition severity and renal or hepatic function. Patients should follow the exact regimen provided by their prescriber and not adjust the dose on their own.

Safety data for ambroxol in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies any possible risk to the fetus or infant. Healthcare providers will assess individual circumstances before recommending treatment to pregnant or nursing women.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ambroxol and acetylcysteine both reduce mucus viscosity, but they act via different mechanisms. Ambroxol primarily stimulates serous secretion and improves ciliary activity, while acetylcysteine breaks disulfide bonds in mucus proteins. Clinical choice often depends on patient tolerance, specific respiratory condition and physician preference.

Store the product at ambient temperature, preferably below 25 °C. Keep it in the original packaging to protect it from moisture and light. Do not store in a refrigerator or freezer unless the label specifically indicates a different requirement.

Mucosolvan 1mal Täglich is taken orally, usually once daily as directed by a healthcare professional. The tablet should be swallowed with a glass of water and can be taken with or without food, unless the prescribing information advises otherwise.

Although rare, serious adverse reactions can include severe allergic responses such as anaphylaxis, Stevens‑Johnson syndrome, eosinophilic pneumonia, significant liver enzyme elevation, neutropenia and angioedema. Patients should seek immediate medical attention if they experience symptoms like rash, swelling, difficulty breathing or unexplained fever.

Individuals with a known hypersensitivity to ambroxol or any component of the formulation should avoid the product. Caution is also advised for patients with severe renal or hepatic impairment, and it should not be used in children under the age recommended by the prescriber without specific medical guidance.